Our surviving patients, after 3 months of combined ART and anti-TB treatment, had a good clinical and immunological response: 61.5% had more than 500 CD4+ T-lymphocytes/μL and 11/13 had undetectable HIV viral load. The gene discussed is CD4; the disease is tuberculosis.